Company / Current Liabilities
ResMed Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$1.0B
FY2025
5-year range
$689.3M / $1.0B
FY2021-FY2025
Trend
+11.9%
vs FY2024
Sector context
#52 of 165
Health Care
What the data says
At $1.0B, ResMed's current liabilities ranks #114 of 165 in the Health Care sector. Current Liabilities has increased for 3 consecutive years, from $689M in FY2022 to $1.0B in FY2025.
Based on SEC 10-K filings.
$1.0B in FY2025 with a 5-year CAGR of +11.1%.
Increased from $759M to $1.0B over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +13.9%
- 5-Year CAGR
- +11.1%
- 10-Year CAGR
- -
Sector benchmark
#114 of 165 in Health CareTop 68% of 165This company $1.0B Sector average $4.4B
▼
-77.0% below sector average
Key checks
Key Insights
- ResMed's current liabilities has grown for 3 consecutive years.
- 5-year CAGR of +11.1%, indicating consistent growth.
- In FY2025, current liabilities increased 11.9% year-over-year.
- Ranks #52 out of 165 companies in the Health Care sector.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.0B | +11.9% |
| FY2024 | $910.7M | +20.1% |
| FY2023 | $758.5M | +10.0% |
| FY2022 | $689.3M | -24.4% |
| FY2021 | $911.8M | +51.3% |
| FY2020 | $602.8M | +8.4% |
| FY2019 | $556.0M | +8.8% |
| FY2018 | $511.2M | +42.0% |
| FY2017 | $360.1M | -43.6% |
| FY2016 | $638.0M | +139.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026